Evaluation of wet cupping therapy with medications versus standard treatment in the management of chronic cases of unspecified low back pain - A randomised controlled clinical trial

IF 2.1 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE
Ramesh Shivappa Killedar , Pradeep Shahajirao Shindhe , Vijay Kage , Rubeen Nadaf , Mahesh Sattigeri
{"title":"Evaluation of wet cupping therapy with medications versus standard treatment in the management of chronic cases of unspecified low back pain - A randomised controlled clinical trial","authors":"Ramesh Shivappa Killedar ,&nbsp;Pradeep Shahajirao Shindhe ,&nbsp;Vijay Kage ,&nbsp;Rubeen Nadaf ,&nbsp;Mahesh Sattigeri","doi":"10.1016/j.jaim.2026.101319","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Unspecified chronic lowback pain (UCLBP) is the most common musculoskeletal condition associated with substantial health and socioeconomic problem. UCLBP does not have a known patho-anatomical origin, thus treatment focuses on minimizing pain and its consequences. Education and reassurance, medications, nonpharmacological therapy, and timely review are all part of the management strategy.</div></div><div><h3>Objective</h3><div>To evaluate the efficacy of Wet Cupping Therapy with Medications versus Standard treatment in the management of chronic cases of unspecified Low Back Pain.</div></div><div><h3>Materials and methods</h3><div>134 participants of either sex, aged between 20 and 70 years, diagnosed with UCLBP were recruited for the study. The participants were divided into trial and standard group by computer generated random number software method. Trial group received two sittings of wet-cupping therapy and medications for 14 days. Control group received TENS and HMP for 7 days, acetaminophen 500 mg twice daily and exercise therapy for 14 days. Assessments of primary and secondary outcome variables were done on day 7, day 14 and follow up was done on day 21 and day 28. Inflammatory biomarkers like TNF alpha and IL 6 were analysed using ELISA. Statistical analysis was done with Chi-square test, Mann Whitney <em>U</em> test, Friedman's ANOVA and Wilcoxon matched pair test to assess the significance between and within group results.</div></div><div><h3>Results</h3><div>Significant results were observed (p &lt; 0.05) in all the assessed outcome variables like VAS, NPRS, VRS, <em>Stambha</em> (stiffness), <em>Gourava</em> (heaviness)<em>,</em> Suptata (numbness) Range of motions, Modified Oswestry disability index, Roland-Morris disability questionnaire, TNF-alpha and IL6, Quality of life assessed by SF-36 questionnaire in within group results at various time points. Comparable results were seen in between group results, in all the assessed outcome variables.</div></div><div><h3>Conclusion</h3><div>Wet Cupping therapy along with medications was effective in managing the UCLBP, improved quality of life, reduced disability and inflammatory biomarkers.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"17 3","pages":"Article 101319"},"PeriodicalIF":2.1000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ayurveda and Integrative Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0975947626000033","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/5/22 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Unspecified chronic lowback pain (UCLBP) is the most common musculoskeletal condition associated with substantial health and socioeconomic problem. UCLBP does not have a known patho-anatomical origin, thus treatment focuses on minimizing pain and its consequences. Education and reassurance, medications, nonpharmacological therapy, and timely review are all part of the management strategy.

Objective

To evaluate the efficacy of Wet Cupping Therapy with Medications versus Standard treatment in the management of chronic cases of unspecified Low Back Pain.

Materials and methods

134 participants of either sex, aged between 20 and 70 years, diagnosed with UCLBP were recruited for the study. The participants were divided into trial and standard group by computer generated random number software method. Trial group received two sittings of wet-cupping therapy and medications for 14 days. Control group received TENS and HMP for 7 days, acetaminophen 500 mg twice daily and exercise therapy for 14 days. Assessments of primary and secondary outcome variables were done on day 7, day 14 and follow up was done on day 21 and day 28. Inflammatory biomarkers like TNF alpha and IL 6 were analysed using ELISA. Statistical analysis was done with Chi-square test, Mann Whitney U test, Friedman's ANOVA and Wilcoxon matched pair test to assess the significance between and within group results.

Results

Significant results were observed (p < 0.05) in all the assessed outcome variables like VAS, NPRS, VRS, Stambha (stiffness), Gourava (heaviness), Suptata (numbness) Range of motions, Modified Oswestry disability index, Roland-Morris disability questionnaire, TNF-alpha and IL6, Quality of life assessed by SF-36 questionnaire in within group results at various time points. Comparable results were seen in between group results, in all the assessed outcome variables.

Conclusion

Wet Cupping therapy along with medications was effective in managing the UCLBP, improved quality of life, reduced disability and inflammatory biomarkers.
评估药物湿罐治疗与标准治疗在治疗慢性不明原因腰痛中的作用——一项随机对照临床试验
背景:不明原因的慢性腰痛(UCLBP)是最常见的与健康和社会经济问题相关的肌肉骨骼疾病。UCLBP没有已知的病理解剖起源,因此治疗的重点是尽量减少疼痛及其后果。教育和安慰、药物治疗、非药物治疗和及时复查都是管理策略的一部分。目的评价湿罐联合药物治疗与标准治疗对慢性不明原因腰痛的疗效。材料与方法研究招募了134名男女参与者,年龄在20至70岁之间,被诊断为UCLBP。采用计算机生成随机数软件方法将参与者分为试验组和标准组。试验组采用湿拔法治疗2次,同时给予药物治疗,疗程14 d。对照组给予TENS和HMP治疗7 d,对乙酰氨基酚500 mg,每日2次,运动治疗14 d。在第7天和第14天评估主要和次要结果变量,并在第21天和第28天进行随访。采用ELISA法分析炎症标志物TNF α和IL 6。统计学分析采用卡方检验、Mann Whitney U检验、Friedman’s ANOVA和Wilcoxon配对对检验来评估组间和组内结果的显著性。结果各组VAS、NPRS、VRS、Stambha(僵硬)、Gourava(沉重感)、Suptata(麻木)活动范围、改良Oswestry残疾指数、rolandmorris残疾问卷、tnf - α和IL6、SF-36生活质量等指标在各时间点的组内结果均有显著性差异(p < 0.05)。在所有评估的结果变量中,组间结果具有可比性。结论湿罐联合药物治疗可有效控制UCLBP,改善生活质量,减少残疾和炎症生物标志物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Ayurveda and Integrative Medicine
Journal of Ayurveda and Integrative Medicine INTEGRATIVE & COMPLEMENTARY MEDICINE-
CiteScore
4.70
自引率
12.50%
发文量
136
审稿时长
30 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书